ES2173487T3 - Nuevo derivado de genipina que tiene actividad contra el virus de hepatitis b. - Google Patents

Nuevo derivado de genipina que tiene actividad contra el virus de hepatitis b.

Info

Publication number
ES2173487T3
ES2173487T3 ES97943212T ES97943212T ES2173487T3 ES 2173487 T3 ES2173487 T3 ES 2173487T3 ES 97943212 T ES97943212 T ES 97943212T ES 97943212 T ES97943212 T ES 97943212T ES 2173487 T3 ES2173487 T3 ES 2173487T3
Authority
ES
Spain
Prior art keywords
genipine
hepatitis
virus
activity against
new derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97943212T
Other languages
English (en)
Inventor
Sung Hwan Moon
Hea Jin Choi
Su Jin Lee
Jea Uk Chung
Jai Hyun Kim
Dong Hoon Chung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Choongwae Pharmaceutical Co Ltd
Original Assignee
Choongwae Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choongwae Pharmaceutical Co Ltd filed Critical Choongwae Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2173487T3 publication Critical patent/ES2173487T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN NUEVO DERIVADO DE GENIPINA REPRESENTADO MEDIANTE LA FORMULA (I), QUE PRESENTA UNA ACTIVIDAD FRENTE AL VIRUS DE LA HEPATITIS B (HBV). EN DICHA FORMULA, R 1 REPRESENTA ALQUILO INFERIOR, BENCILO, ETC., R SUB,2 REPRESENTA HIDROXIMETILO, FORMILO, ACETILO, ETC., R SUB,3 REPRESENTA METOXICARBONILO, FORMILO, ETC. SE INCLUYEN ASIMISMO SU SAL FARMACEUTICAMENTE ACEPTABLE Y SU ESTEREOISOMERO.
ES97943212T 1996-10-18 1997-10-08 Nuevo derivado de genipina que tiene actividad contra el virus de hepatitis b. Expired - Lifetime ES2173487T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019960046732A KR100197744B1 (ko) 1996-10-18 1996-10-18 항 b형 간염 바이러스 활성을 갖는 신규한 제니핀 유도체

Publications (1)

Publication Number Publication Date
ES2173487T3 true ES2173487T3 (es) 2002-10-16

Family

ID=19477974

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97943212T Expired - Lifetime ES2173487T3 (es) 1996-10-18 1997-10-08 Nuevo derivado de genipina que tiene actividad contra el virus de hepatitis b.

Country Status (8)

Country Link
US (1) US6162826A (es)
EP (1) EP0956285B1 (es)
JP (1) JP2001502687A (es)
KR (1) KR100197744B1 (es)
AU (1) AU4473697A (es)
DE (1) DE69712101T2 (es)
ES (1) ES2173487T3 (es)
WO (1) WO1998017663A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6624138B1 (en) 2001-09-27 2003-09-23 Gp Medical Drug-loaded biological material chemically treated with genipin
US7351421B2 (en) * 1996-11-05 2008-04-01 Hsing-Wen Sung Drug-eluting stent having collagen drug carrier chemically treated with genipin
US7282220B1 (en) 1996-11-05 2007-10-16 Hsing-Wen Sung Genipin-crosslinked gelatin microspheres as drug carrier
US7101857B2 (en) * 1996-11-05 2006-09-05 Gp Medical, Inc. Crosslinkable biological material and medical uses
US6545042B2 (en) 1996-11-05 2003-04-08 Gp Medical Acellular biological material chemically treated with genipin
US20050163818A1 (en) * 1996-11-05 2005-07-28 Hsing-Wen Sung Drug-eluting device chemically treated with genipin
US6998418B1 (en) 1996-11-05 2006-02-14 Gp Medical, Inc. Acellular biological material chemically treated with genipin
US6262083B1 (en) 1997-11-05 2001-07-17 Choongwae Pharma Corporation Genipin derivative having liver protection activity
KR100704710B1 (ko) * 1999-10-29 2007-04-09 주식회사 중외제약 간 섬유화 억제작용을 나타내는 벤조[3,4-ｄ]1,3-디옥솔란 유도체
US20050171616A1 (en) * 2002-02-04 2005-08-04 Hsing-Wen Sung Peritoneal regeneration with acellular pericardial patch
EP1545505A4 (en) * 2002-08-02 2008-01-02 Gp Medical BIOLOGICAL MATERIAL CHARGED WITH CHEMICALLY TREATED MEDICINE BY GENIPINE
US20050163821A1 (en) * 2002-08-02 2005-07-28 Hsing-Wen Sung Drug-eluting Biodegradable Stent and Delivery Means
US20050019404A1 (en) * 2003-06-30 2005-01-27 Hsing-Wen Sung Drug-eluting biodegradable stent
WO2004089926A2 (en) * 2003-03-31 2004-10-21 Beth Israel Deaconess Medical Center, Inc. Genipin derivatives and uses thereof
CN102875518A (zh) * 2012-09-26 2013-01-16 苏州雷纳药物研发有限公司 京尼平甲醚、其制备方法及其医药用途
CN102993158B (zh) * 2012-11-26 2015-07-22 蕾硕医药化工（长沙）有限公司 京尼平衍生物及其用途
WO2014165023A1 (en) 2013-03-12 2014-10-09 Carnegie Mellon University Coated vaso-occclusive device for treatment of aneurysms
FR3003860B1 (fr) * 2013-03-29 2015-11-27 Oreal Composes derives d'iridoides proteges ou non, composition les comprenant, utilisation comme colorant des fibres keratiniques et dispositifs
CN104892562B (zh) * 2015-06-16 2017-03-15 吴虹 抑制环氧化酶‑2的化合物及其制备方法和应用
TWI641594B (zh) * 2016-04-19 2018-11-21 中國醫藥大學 用於治療中風的環烯醚萜苷類化合物，其醫藥組合物及其用途
CN107400128B (zh) * 2017-07-27 2020-03-31 贵州省中国科学院天然产物化学重点实验室 拟单萜吲哚生物碱及其制备方法和应用
JP2023537873A (ja) * 2020-08-12 2023-09-06 インクボックス インク インコーポレイテッド 半永久的な入れ墨
CN113831316B (zh) * 2021-10-13 2023-04-04 陕西中医药大学 一种1-o-烷基京尼平及其制备方法和应用
CN116640110B (zh) * 2023-05-31 2025-02-11 陕西中医药大学 一种1-o-烷基京尼平衍生物的制备方法
CN118702668B (zh) * 2024-07-05 2025-09-05 陕西中医药大学 一种1-s-烷基京尼平衍生物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2540871B2 (ja) * 1987-07-20 1996-10-09 株式会社ツムラ 抗高脂血症剤
KR927003493A (ko) * 1990-10-09 1992-12-18 주식회사 쓰무라 이리도이드 유도체 및 그의 의약으로서의 사용
KR100218052B1 (ko) * 1992-07-15 1999-09-01 이병언 B형 간염 바이러스의 복제를 억제하는 약학적 제제

Also Published As

Publication number Publication date
KR100197744B1 (ko) 1999-06-15
JP2001502687A (ja) 2001-02-27
AU4473697A (en) 1998-05-15
KR19980027826A (ko) 1998-07-15
EP0956285A1 (en) 1999-11-17
WO1998017663A1 (en) 1998-04-30
US6162826A (en) 2000-12-19
DE69712101D1 (de) 2002-05-23
EP0956285B1 (en) 2002-04-17
DE69712101T2 (de) 2002-10-31

Similar Documents

Publication Publication Date Title
ES2173487T3 (es) Nuevo derivado de genipina que tiene actividad contra el virus de hepatitis b.
MXPA02012443A (es) Profarmaco en 3'' de 2'-desoxi-beta-l-nucleosidos.
HRP20041085B1 (hr) Inhibitori hepatitis c virusa
IS8448A (is) Lifrarbólgu C-veirutálmar
ES2190075T3 (es) Formulaciones farmaceuticas solidas que contienen una mezcla fisica de sulfoalquil-eter-ciclodextrina y un agente terapeutico.
ECSP045104A (es) Ligandos de los receptores de los cannabinoides
ECSP034660A (es) Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen
SE9502168D0 (sv) Insulinanalog-kompositioner
NO952151L (no) Injiserbare, taxanderivat-baserte preparater
BR0112540A (pt) Peptìdios como inibidores da ns-3-serina protease do vìrus da hepatite c
WO2005054430A3 (en) Hepatitis c virus inhibitors
ATE192649T1 (de) Stereochemische wortmanninderivate
MA26877A1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
GT199700016A (es) Derivados de triazol utiles en terapia
WO2002008198A3 (en) Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus
PT1268519E (pt) Inibidores de serina protease, particularmente protease ns3 do virus da hepatite c
ES2112650T3 (es) Sales de un derivado de indol antimigraña.
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
ES2167463T3 (es) Componentes de un compuesto medicinal que comprenden derivados n-sustituidos de la o-toluidina y preparacion percutaneamente absorbible.
DE60228436D1 (de) Verwendung von castanospermine derivaten in der behandlung von hepatitis c
ES2140652T3 (es) Uso de n-alquil-derivados de 1,5-didesoxi-1,5-imino-d-glucitol para el tratamiento de infecciones por el virus de la hepatitis b.
DE69708340D1 (de) Arylsulfonylimidazolon-derivate als antitumormittel
NO20002600D0 (no) Mellomprodukter og fremgangsmÕter for anvendelse ved semisyntesen av paclitaxel og analoger
ATE262507T1 (de) Substituierte n-phenyl-2-hydroxy-2-methyl-3,3,3- trifluorpropanamid-derivative zur erhöhung der pyruvatdehydrogenaseaktivität
AR001507A1 (es) Derivados de pirazol y herbicida que lo contiene.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 956285

Country of ref document: ES